Expression of vascular endothelial growth factor (VEGF)‐C and VEGF‐D, and their receptor VEGFR‐3, during different stages of cervical carcinogenesis
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Cervical carcinogenesis has well‐defined stages of disease progression including three grades of pre‐invasive lesions—cervical intraepithelial neoplasia grades 1–3 (CIN 1–3)—and invasive cervical cancer. However, the biological properties of CIN lesions prone to develop invasive disease are not well defined. Recent observations suggest that early invasive disease spreads to regional lymph nodes in several tumour types and that growth factors (VEGF‐C and VEGF‐D) involved in new lymphatic vessel formation may play a crucial role in this process. The present study has assessed the expression of VEGF‐C and VEGF‐D, and their receptor VEGFR‐3, in 152 cervical lesions (33 CIN 1, 33 CIN 2, 37 CIN 3, and 49 squamous cell carcinomas) to determine whether expression of lymphangiogenic factors occurs prior to invasion. The presence of lymphatic vessels was determined using LYVE‐1 and podoplanin staining, as well as double immunostaining for LYVE‐1/CD34 and podoplanin/CD34. In situ hybridization was performed to determine VEGFR‐3 mRNA expression. A significant positive correlation was found between VEGF‐C, VEGF‐D, and VEGFR‐3 expression through the different stages of cervical carcinogenesis. Significant differences in protein expression for VEGF‐C, VEGF‐D, and VEGFR‐3 were found between CIN 1–2 and CIN 3 ( p < 0.001 for all), but not between CIN 3 and cervical cancer. More than 50% of the CIN 3 lesions showed moderate to strong staining for VEGF‐C and VEGF‐D, whereas most of the early pre‐cancerous lesions (CIN 1 and 2) were negative. In cervical cancer, similar observations to those in CIN 3 were found. VEGFR‐3 mRNA expression was found in the cytoplasm of epithelial neoplastic cells and VEGFR3 protein expression was found in more than 50% of CIN 3 lesions and cervical cancers, compared with 15% in CIN 1 and 2. These findings suggest an autocrine growth stimulation pattern via VEGFR‐3. Adjacent CIN 3 was present in nine cervical cancers and displayed strong expression for VEGF‐C, VEGF‐D, and VEGFR‐3. These results suggest that in cervical carcinogenesis a switch to the lymphangiogenic phenotype may occur at the stage of CIN 3. Copyright © 2003 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Induction of angiogenesis during the transition from hyperplasia to neoplasia
Folkman, J., Watson, K., Ingber, D., & Hanahan, D. (1989) · Nature · doi:10.1038/339058a0 · Cited by 1,879
Cited by
Goel, H. L., & Mercurio, A. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3627 · Cited by 1,253
Vascular endothelial growth factor (VEGF) signaling in tumor progression
Roskoski, R. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.01.006 · Cited by 599
The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells
Su, J.-L., Yang, P.-C., Shih, J.-Y., Yang, C.-Y., Wei, L.-H., Hsieh, C.-Y., Chou, C.-H., Jeng, Y.-M., Wang, M.-Y., Chang, K.-J., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.018 · Cited by 348
Catarino, R. (2015) · World Journal of Clinical Oncology · doi:10.5306/wjco.v6.i6.281 · Cited by 284
The role of the VEGF-C/VEGFR-3 axis in cancer progression
Su, J.-L., Yen, C.-J., Chen, P.-S., Chuang, S.-E., Hong, C.-C., Kuo, I.-H., Chen, H.-Y., Hung, M.-C., & Kuo, M.-L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603487 · Cited by 252
Hokari, R., Kitagawa, N., Watanabe, C., Komoto, S., Kurihara, C., Okada, Y., Kawaguchi, A., Nagao, S., Hibi, T., & Miura, S. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05225.x · Cited by 70
Hsu, M.-C., Pan, M.-R., & Hung, W.-C. (2019) · Cells · doi:10.3390/cells8030270 · Cited by 67
Takao, A., Yoshikawa, K., Karnan, S., Ota, A., Uemura, H., De Velasco, M., Kura, Y., Suzuki, S., Ueda, R., Nishino, T., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6683 · Cited by 26
Metadata
- Authors
- Van Trappen, P. O., Steele, D., Lowe, D. G., Baithun, S., Beasley, N., Thiele, W., Weich, H., Krishnan, J., Shepherd, J. H., Pepper, M. S., Jackson, D. G., Sleeman, J. P., & Jacobs, I. J.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2003-09-26
- Volume
- 201
- Issue
- 4
- Pages
- 544-554
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2024064139
- Cited by
- 147
- References
- 2
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.